Greece vs Lithuania: Access to anti-retroviral drugs, female
Greece
57.0%
in 2024
Lithuania
56.0%
in 2024
Greece rank
108th
Lithuania rank
110th
Access to anti-retroviral drugs, female over time
- Greece
- Lithuania
How they compare
Greece currently reports 57.0% against 56.0% in Lithuania, a difference of 1.0%.
Across all 25 years both countries report, Greece has been ahead every year.
Greece ranks 108th and Lithuania ranks 110th of 141 countries.
Greece has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Greece | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.3% | 2.3% | 42.0% | Greece |
| 2010s | 49.7% | 20.7% | 29.0% | Greece |
| 2020s | 55.6% | 45.8% | 9.8% | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Greece or Lithuania?
- Greece, at 57.0% against 56.0% in Lithuania as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Greece and Lithuania?
- 1.0%, with Greece ahead.
- How many years of comparable data are there for Greece and Lithuania?
- 25 years are reported by both, from 2000 to 2024.
- How do Greece and Lithuania rank globally for access to anti-retroviral drugs, female?
- Greece ranks 108th and Lithuania ranks 110th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.